COVID-19
From the Chief Medical Officer: Pediatric COVID-19 vaccines now available
November 5, 2021
UT Health San Antonio offers COVID-19 Pfizer-BioNTech pediatric vaccine for children 5 to 11 years old. Convenient appointments can be scheduled online for both children and adults.
Nationwide study testing ivermectin and other drugs conducted at UT Health San Antonio
November 5, 2021
A large, multi-site study funded by the National Institutes of Health aims to test the effectiveness of three existing drugs, including controversial ivermectin, to treat the symptoms of COVID-19. Known as ACTIV-6, the study is now underway at UT Health San Antonio.
Important facts to know about COVID-19 vaccinations
November 4, 2021
This quick and helpful Q&A video speaks to vaccine symptoms, the importance of booster shots and other timely topics.
From the Chief Medical Officer: COVID-19 vaccine approved for children ages 5 to 11
November 3, 2021
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has endorsed the recommendation that children 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine.
Ask the expert: Are COVID-19 vaccines safe for young children?
November 1, 2021
On Oct. 26, the Food and Drug Administration approved COVID-19 vaccinations for children ages 5 to 11. The decision will now go before the CDC Advisory Committee on Immunization Practices’ (ACIP) for a final recommendation Nov. 2-3.
Post-COVID study to enroll 900 in South Texas
October 29, 2021
Researchers at The University of Texas Health Science Center at San Antonio, who see patients at University Health, are recruiting 900 adult COVID-19 survivors for a federally funded study that seeks to understand why some people have prolonged symptoms or develop new or returning symptoms after the acute phase of SARS-CoV-2 infection. The partnership also includes the Laredo Health Department as a clinical partner in this major effort.